MOLINEAUX, Susan,GROSS, Matthew,BROMLEY, Susan,PARLATI, Francesco,BENNETT, Mark
申请号：
SG11201802830Q
公开号：
SG11201802830QA
申请日:
2016.10.04
申请国别(地区):
SG
年份:
2018
代理人:
摘要：
The invention relates to methods of treating cancer, myeloproliferative diseases, or immunological or neurological diseases with a combination of a glutaminase inhibitor and an immuno-oncology therapeutic agent, such as an inhibitor of arginase, CTLA-4, indoleamine 2,3-dioxygenase, and/or PD-1/PD-L1.
